{"id":12509,"date":"2021-02-17T09:36:08","date_gmt":"2021-02-17T15:36:08","guid":{"rendered":"https:\/\/saluddigital.com\/?p=12509"},"modified":"2025-10-21T13:02:06","modified_gmt":"2025-10-21T19:02:06","slug":"la-fda-aprueba-inteligencia-artificial-para-apoyar-en-pacientes-en-cuidados-intensivos","status":"publish","type":"post","link":"https:\/\/saluddigital.com\/en\/avance-de-la-ciencia\/la-fda-aprueba-inteligencia-artificial-para-apoyar-en-pacientes-en-cuidados-intensivos\/","title":{"rendered":"FDA approves Artificial Intelligence to support intensive care patients"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Artificial Intelligence, developed by an Israel-based company, is able to constantly monitor risk levels of ICU patients and predict hemodynamic instability in patients.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CLEW Medical, a company founded in Israel in 2014, recently got one of its solutions in Artificial Intelligence (AI), approved by the FDA (Food and Drug Administration) in the United States. CLEWICU, is an AI-based development capable of monitoring the risk level of patients by making physicians aware of the likelihood of the ICU patient presenting hemodynamic instability.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u201cAI can be a powerful force for change in healthcare, enabling assessment of time-critical patient information and predictive warning of deterioration that could enable better informed clinical decisions and improved outcomes in the ICU,\u201d said Dr. David Bates, member of CLEW Advisory Board.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The innovation has received 510(k), the FDA's premarket notification for a medical device. Moreover, according to the Israeli company, it is the first solution of its kind to be approved. \u201cWe are proud to have received this landmark FDA clearance and deliver a first-of-its-kind product for the industry, giving healthcare providers the critical data that they need to prevent life-threatening situations,\u201d explained Gal Salomon, CEO of CLEW.<\/p>

Hemodynamic instability occurs when the heart is not pumping strongly enough and the circulatory system is not able to supply blood to the entire body. CLEWICU, is able to give an 8-hour advance warning by analyzing hemodynamic data in patients' electronic health records. In addition, it not only identifies ICU patients who may suffer from this condition, but also classifies patients at low risk for the condition.<\/p>

\u201cCLEW's AI-based solution is a huge leap forward in ICU patient care, providing preemptive and potentially lifesaving information that enables early intervention, reduces alarm fatigue and can potentially significantly improve clinical outcomes,\u201d said Dr. Craig Lilly of the University of Massachusetts Medical School.<\/p>

This solution comes at an opportune time, with fewer hospital beds being occupied mostly by COVID-19 patients, this tool is able to manage hospital resources and make better and faster decisions.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t BIBLIOGRAPHY<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

HEALTHCARE IT NEWS<\/strong><\/p>

https:\/\/www.healthcareitnews.com\/news\/fda-issues-landmark-clearance-ai-driven-icu-predictive-tool<\/a><\/p>

\u00a0<\/strong><\/p>

HIT INFRASTRUCTURE <\/strong><\/p>

https:\/\/hitinfrastructure.com\/news\/fda-approves-clew-medicals-artificial-intelligence-icu-solution<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

La Inteligencia Artificial desarrollada por una compa\u00f1\u00eda israel\u00ed, es capaz de monitorear constantemente los niveles de riesgo de los pacientes en UCI y predecir la inestabilidad hemodin\u00e1mica en pacientes. CLEW Medical, compa\u00f1\u00eda fundada en Israel en 2014, consigui\u00f3 recientemente que una de sus soluciones en Inteligencia Artificial (IA), fuera aprobada por la FDA (Administraci\u00f3n de Alimentos y Medicamentos) en Estados Unidos. CLEWICU, es un desarrollo basado en IA capaz de monitorear el nivel de riesgo de pacientes logrando que los m\u00e9dicos conozcan la probabilidad de que el paciente en UCI presente inestabilidad hemodin\u00e1mica. \u201cLa IA puede ser una fuerza poderosa para el cambio en el cuidado de la salud, permitiendo la evaluaci\u00f3n de la informaci\u00f3n del paciente de tiempo cr\u00edtico y la advertencia predictiva del deterioro que podr\u00eda permitir decisiones cl\u00ednicas mejor informadas y mejores resultados en la UCI\u201d, dijo el Dr. David Bates, miembro de la Junta de Asesores de CLEW. La innovaci\u00f3n ha recibido la 510(k), la notificaci\u00f3n previa a la comercializaci\u00f3n de un dispositivo m\u00e9dico que otorga la FDA. Adem\u00e1s, seg\u00fan la compa\u00f1\u00eda israel\u00ed, es la primera soluci\u00f3n de este tipo que se aprueba. \u201cEstamos orgullosos de haber recibido esta autorizaci\u00f3n hist\u00f3rica de la FDA y de entregar un producto \u00fanico en su tipo para la industria, brindando a los proveedores de atenci\u00f3n m\u00e9dica los datos cr\u00edticos que necesitan para prevenir situaciones que amenazan la vida\u201d, explic\u00f3 Gal Salomon, CEO de CLEW. La inestabilidad hemodin\u00e1mica sucede cuando el coraz\u00f3n no est\u00e1 bombeando con fuerza suficiente y el sistema circulatorio no es capaz de suministrar sangre a todo el cuerpo. CLEWICU, es capaz de avisar con 8 horas de antelaci\u00f3n, al analizar datos de hemodinamia en los registros de salud electr\u00f3nicos de los pacientes.  Adem\u00e1s, no solo identifica a los pacientes de ICU que pueden sufrir esta condici\u00f3n, sino que tambi\u00e9n clasifica a los pacientes de bajo riesgo de padecerla. “La soluci\u00f3n basada en inteligencia artificial de CLEW es un gran paso adelante en la atenci\u00f3n al paciente de la UCI, ya que proporciona informaci\u00f3n preventiva y potencialmente salvadora que permite una intervenci\u00f3n temprana, reduce la fatiga de las alarmas y puede mejorar significativamente los resultados cl\u00ednicos”, dijo el Dr. Craig Lilly de la Facultad de Medicina de la Universidad de Massachusetts. Esta soluci\u00f3n llega en un momento indicado, al contar con menos camas en hospitales tras ser ocupadas en su mayor\u00eda por pacientes COVID-19, esta herramienta es capaz de gestionar los recursos de los hospitales y tomar mejores y m\u00e1s r\u00e1pidas decisiones. BIBLIOGRAF\u00cdA HEALTHCARE IT NEWS https:\/\/www.healthcareitnews.com\/news\/fda-issues-landmark-clearance-ai-driven-icu-predictive-tool   HIT INFRASTRUCTURE https:\/\/hitinfrastructure.com\/news\/fda-approves-clew-medicals-artificial-intelligence-icu-solution<\/p>","protected":false},"author":1,"featured_media":12510,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[152,156],"tags":[145],"class_list":["post-12509","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-avance-de-la-ciencia","category-big-data","tag-noticias"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/12509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/comments?post=12509"}],"version-history":[{"count":0,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/12509\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media\/12510"}],"wp:attachment":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media?parent=12509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/categories?post=12509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/tags?post=12509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}